These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37966571)

  • 21. Pharmacological properties and underlying mechanisms of curcumin and prospects in medicinal potential.
    Fu YS; Chen TH; Weng L; Huang L; Lai D; Weng CF
    Biomed Pharmacother; 2021 Sep; 141():111888. PubMed ID: 34237598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The enhanced bioavailability of free curcumin and bioactive-metabolite tetrahydrocurcumin from a dispersible, oleoresin-based turmeric formulation.
    Panda SK; Nirvanashetty S; Missamma M; Jackson-Michel S
    Medicine (Baltimore); 2021 Jul; 100(27):e26601. PubMed ID: 34232211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioavailable curcumin formulations: A review of pharmacokinetic studies in healthy volunteers.
    Jamwal R
    J Integr Med; 2018 Nov; 16(6):367-374. PubMed ID: 30006023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curcumin combined with photodynamic therapy, promising therapies for the treatment of cancer.
    Xie L; Ji X; Zhang Q; Wei Y
    Biomed Pharmacother; 2022 Feb; 146():112567. PubMed ID: 34953392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obstacles against the Marketing of Curcumin as a Drug.
    Hassanzadeh K; Buccarello L; Dragotto J; Mohammadi A; Corbo M; Feligioni M
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32927725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curcumin for chemoprevention of colon cancer.
    Johnson JJ; Mukhtar H
    Cancer Lett; 2007 Oct; 255(2):170-81. PubMed ID: 17448598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curcumin Supplementation and Human Disease: A Scoping Review of Clinical Trials.
    Panknin TM; Howe CL; Hauer M; Bucchireddigari B; Rossi AM; Funk JL
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined therapy using bevacizumab and turmeric ethanolic extract (with absorbable curcumin) exhibited beneficial efficacy in colon cancer mice.
    Yue GG; Kwok HF; Lee JK; Jiang L; Wong EC; Gao S; Wong HL; Li L; Chan KM; Leung PC; Fung KP; Zuo Z; Lau CB
    Pharmacol Res; 2016 Sep; 111():43-57. PubMed ID: 27241019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Curcumin, a component of turmeric: from farm to pharmacy.
    Gupta SC; Kismali G; Aggarwal BB
    Biofactors; 2013; 39(1):2-13. PubMed ID: 23339055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current clinical developments in curcumin-based therapeutics for cancer and chronic diseases.
    Kumar A; Harsha C; Parama D; Girisa S; Daimary UD; Mao X; Kunnumakkara AB
    Phytother Res; 2021 Dec; 35(12):6768-6801. PubMed ID: 34498308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmaceutical strategies of improving oral systemic bioavailability of curcumin for clinical application.
    Ma Z; Wang N; He H; Tang X
    J Control Release; 2019 Dec; 316():359-380. PubMed ID: 31682912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis.
    Sahebkar A
    Phytother Res; 2014 May; 28(5):633-42. PubMed ID: 23922235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phytosomal curcumin: A review of pharmacokinetic, experimental and clinical studies.
    Mirzaei H; Shakeri A; Rashidi B; Jalili A; Banikazemi Z; Sahebkar A
    Biomed Pharmacother; 2017 Jan; 85():102-112. PubMed ID: 27930973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of a Single Dose of Turmeric Curcuminoids Depends on Formulation: Results of a Human Crossover Study.
    Fança-Berthon P; Tenon M; Bouter-Banon SL; Manfré A; Maudet C; Dion A; Chevallier H; Laval J; van Breemen RB
    J Nutr; 2021 Jul; 151(7):1802-1816. PubMed ID: 33877323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Adequate and clinically effective levels of curcumin consumption].
    Kodentsova VM; Risnik DV; Sarkisyan VA; Frolova YV
    Vopr Pitan; 2022; 91(5):6-15. PubMed ID: 36394925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A review of therapeutic potentials of turmeric (Curcuma longa) and its active constituent, curcumin, on inflammatory disorders, pain, and their related patents.
    Razavi BM; Ghasemzadeh Rahbardar M; Hosseinzadeh H
    Phytother Res; 2021 Dec; 35(12):6489-6513. PubMed ID: 34312922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Daily JW; Yang M; Park S
    J Med Food; 2016 Aug; 19(8):717-29. PubMed ID: 27533649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Curcumin and Melanoma: From Chemistry to Medicine.
    Nabavi SM; Russo GL; Tedesco I; Daglia M; Orhan IE; Nabavi SF; Bishayee A; Nagulapalli Venkata KC; Abdollahi M; Hajheydari Z
    Nutr Cancer; 2018; 70(2):164-175. PubMed ID: 29300102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases.
    Aggarwal BB; Harikumar KB
    Int J Biochem Cell Biol; 2009 Jan; 41(1):40-59. PubMed ID: 18662800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Golden Spice for Life: Turmeric with the Pharmacological Benefits of Curcuminoids Components, Including Curcumin, Bisdemethoxycurcumin, and Demethoxycurcumins.
    Shahrajabian MH; Sun W
    Curr Org Synth; 2024; 21(5):665-683. PubMed ID: 37287298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.